Xtant Medical Holdings, Inc. earnings per share and revenue
On Nov 10, 2025, XTNT reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of 0.00 USD, resulting in a 296.08% surprise. Revenue reached 33.26 million, compared to an expected 33.35 million, with a -0.30% difference. The market reacted with a -0.62% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 31.36 million USD, implying an decrease of -100.00% EPS, and decrease of -5.68% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Intuitive Surgical Inc.
Report Date
Jan 22, 2026 For Q4 25
Estimate
$2.30
Actual
$2.52
Surprise
+9.86%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.63%
FAQ
What were Xtant Medical Holdings, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Xtant Medical Holdings, Inc. reported EPS of $0.01, beating estimates by 296.08%, and revenue of $33.26M, -0.3% below expectations.
How did the market react to Xtant Medical Holdings, Inc.'s Q3 2025 earnings?
The stock price moved down -0.62%, changed from $0.76 before the earnings release to $0.76 the day after.
When is Xtant Medical Holdings, Inc. expected to report next?
The next earning report is scheduled for Mar 04, 2026.
What are the forecasts for Xtant Medical Holdings, Inc.'s next earnings report?
Based on 4
analysts, Xtant Medical Holdings, Inc. is expected to report EPS of -- and revenue of $31.36M for Q4 2025.